S

Active Director Director DIN 09541204
DIN 09541204 First appointment Mar 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value •••• Premium profile

About Shaista

Data last updated:

Shaista is a Director at Dayra Pharmaceutical Private Limited (since 2022). The company operates in Pharma. Dayra Pharmaceutical Private Limited reported revenue of ₹7.6 Lakh (FY 2025).

DIN 09541204
Primary Designation Director
Industry Pharma
First Appointment 21 Mar 2022
Oldest Company Age 4 yrs
Largest company Dayra Pharmaceutical Private Limited · ₹7.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dayra Pharmaceutical Private Limited U51909DL2022PTC395248
Director21 Mar 20222022₹7.6 Lakh (FY 2025)Active

Board colleagues of Shaista

Directorship timeline

Open interactive timeline →
Dayra Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Shaista

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shaista

Shaista currently holds 1 directorship: Dayra Pharmaceutical Private Limited (Director, since 21 Mar 2022, revenue ₹7.6 Lakh (FY 2025)).

Shaista was first appointed on 21 Mar 2022 as Director at Dayra Pharmaceutical Private Limited.

The current boards of Shaista's companies include Faheem Ahmed (Dayra Pharmaceutical Private Limited), Mohd Asim (Dayra Pharmaceutical Private Limited), Mohd Faizan (Dayra Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available